Odors lead to back order for Pfizer's Levoxyl

Drugs being pulled off of shelves because of bad odors generally have no health risks associated with them, but they cost drugmakers money and consumers inconvenience. Pfizer ($PFE) subsidiary King Pharmaceuticals is recalling 52,000 bottles of its thyroid pill Levoxyl because of a bad odor. The problem was tracked to the oxygen-absorbing canisters in 100-count and 1,000-count bottles but the company decided to pull all of its supplies as a precaution, which landed it on the FDA shortage list. The company said it does not expect to have supplies until 2014. Story | More (PDF)